DK0983765T3 - Forebyggende midler eller lægemidler mod sygdomme i forbindelse med vaskulær funktionel anomali i relation til insulinresistens - Google Patents
Forebyggende midler eller lægemidler mod sygdomme i forbindelse med vaskulær funktionel anomali i relation til insulinresistensInfo
- Publication number
- DK0983765T3 DK0983765T3 DK99906501T DK99906501T DK0983765T3 DK 0983765 T3 DK0983765 T3 DK 0983765T3 DK 99906501 T DK99906501 T DK 99906501T DK 99906501 T DK99906501 T DK 99906501T DK 0983765 T3 DK0983765 T3 DK 0983765T3
- Authority
- DK
- Denmark
- Prior art keywords
- insulin resistance
- preventives
- drugs
- relation
- diseases related
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP04772098A JP4306825B2 (ja) | 1998-02-27 | 1998-02-27 | インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0983765T3 true DK0983765T3 (da) | 2007-01-02 |
Family
ID=12783164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99906501T DK0983765T3 (da) | 1998-02-27 | 1999-02-26 | Forebyggende midler eller lægemidler mod sygdomme i forbindelse med vaskulær funktionel anomali i relation til insulinresistens |
Country Status (9)
Country | Link |
---|---|
US (1) | US6410535B1 (de) |
EP (1) | EP0983765B1 (de) |
JP (1) | JP4306825B2 (de) |
AT (1) | ATE340575T1 (de) |
DE (1) | DE69933347T2 (de) |
DK (1) | DK0983765T3 (de) |
ES (1) | ES2272052T3 (de) |
PT (1) | PT983765E (de) |
WO (1) | WO1999043325A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7442372B2 (en) | 2003-08-29 | 2008-10-28 | Biomarin Pharmaceutical Inc. | Delivery of therapeutic compounds to the brain and other tissues |
EP1708690B1 (de) * | 2003-11-17 | 2016-07-20 | BioMarin Pharmaceutical Inc. | Behandlung von phenylketonurie mit bh4 |
CN101132776A (zh) | 2004-11-17 | 2008-02-27 | 生物马林药物股份有限公司 | 稳定的四氢生物喋呤片剂制剂 |
US20100130500A1 (en) * | 2004-12-08 | 2010-05-27 | Biomarin Pharmaceutical Inc. | Methods and compositions for the treatment of pulmonary hypertension of the newborn |
TW200719896A (en) * | 2005-04-18 | 2007-06-01 | Astrazeneca Ab | Combination product |
JP2009518415A (ja) * | 2005-12-05 | 2009-05-07 | バイオマリン ファーマシューティカル インコーポレイテッド | 疾患の処置のための方法および組成物 |
JP2010515747A (ja) * | 2007-01-12 | 2010-05-13 | ビオマリン プハルマセウトイカル インコーポレイテッド | テトラヒドロビオプテリンプロドラッグ |
WO2008089148A1 (en) * | 2007-01-12 | 2008-07-24 | Biomarin Pharmaceutical Inc. | Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug |
HUE058030T2 (hu) | 2007-04-11 | 2022-06-28 | Biomarin Pharm Inc | Tetrahidrobiopterin emelt fenilalanin szintekkel összefüggõ állapotok kezelésében történõ alkalmazásra |
AU2008347005B2 (en) | 2008-01-03 | 2013-10-03 | Biomarin Pharmaceutical Inc. | Pterin analog for treating BH4 responsive condition |
JP5559656B2 (ja) * | 2010-10-14 | 2014-07-23 | 大日本スクリーン製造株式会社 | 熱処理装置および熱処理方法 |
US9216178B2 (en) | 2011-11-02 | 2015-12-22 | Biomarin Pharmaceutical Inc. | Dry blend formulation of tetrahydrobiopterin |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5925323A (ja) * | 1982-03-03 | 1984-02-09 | 鐘淵化学工業株式会社 | プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤 |
AU572792B2 (en) | 1982-09-20 | 1988-05-19 | Wellcome Foundation Limited, The | 2-amino, 4-oxo-pteridine derivatives |
ZA836957B (en) | 1982-09-20 | 1985-04-24 | Wellcome Found | Neurologically active chemical compounds |
JPS61277618A (ja) | 1985-06-04 | 1986-12-08 | Suntory Ltd | 自閉症治療剤 |
JP2588191B2 (ja) * | 1987-04-24 | 1997-03-05 | サントリー株式会社 | 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤 |
JPH0656669A (ja) * | 1992-06-11 | 1994-03-01 | Asahi Breweries Ltd | 活性酸素消去作用を持つプテリン誘導体製剤 |
ES2177654T3 (es) | 1994-08-05 | 2002-12-16 | Suntory Ltd | Remedio contra la degeneracion espinocerebelosa. |
-
1998
- 1998-02-27 JP JP04772098A patent/JP4306825B2/ja not_active Expired - Lifetime
-
1999
- 1999-02-26 EP EP99906501A patent/EP0983765B1/de not_active Expired - Lifetime
- 1999-02-26 DE DE69933347T patent/DE69933347T2/de not_active Expired - Lifetime
- 1999-02-26 DK DK99906501T patent/DK0983765T3/da active
- 1999-02-26 PT PT99906501T patent/PT983765E/pt unknown
- 1999-02-26 WO PCT/JP1999/000917 patent/WO1999043325A1/ja active IP Right Grant
- 1999-02-26 ES ES99906501T patent/ES2272052T3/es not_active Expired - Lifetime
- 1999-02-26 AT AT99906501T patent/ATE340575T1/de active
- 1999-10-27 US US09/427,579 patent/US6410535B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0983765A1 (de) | 2000-03-08 |
ES2272052T3 (es) | 2007-04-16 |
EP0983765A4 (de) | 2001-04-04 |
JPH11246410A (ja) | 1999-09-14 |
JP4306825B2 (ja) | 2009-08-05 |
PT983765E (pt) | 2006-12-29 |
WO1999043325A1 (fr) | 1999-09-02 |
US6410535B1 (en) | 2002-06-25 |
DE69933347T2 (de) | 2007-05-03 |
US20020082261A1 (en) | 2002-06-27 |
ATE340575T1 (de) | 2006-10-15 |
DE69933347D1 (de) | 2006-11-09 |
EP0983765B1 (de) | 2006-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0908182A4 (de) | Vorbeugende oder heilende mittel für krankheiten, die durch mangel an stickoxid-synthase (nos) ausgelöst ist | |
CY1108367T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
GB8929070D0 (en) | Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same | |
EP2407470A3 (de) | Makrocyclische Carbonsäuren und Acylsulfonamide als Hemmer der HCV-Replikation | |
DK0983765T3 (da) | Forebyggende midler eller lægemidler mod sygdomme i forbindelse med vaskulær funktionel anomali i relation til insulinresistens | |
WO2005056524A3 (en) | Therapeutic agents useful for treating pain | |
ATE181553T1 (de) | Kondensierte thiazolverbindungen, ihre darstellung und ihre anwendung | |
IL111036A0 (en) | Beta_alanine derivatives, processes for the preparon thereof and pharmaceutical compositions containing the same | |
EP1147772A4 (de) | Medizinische zusammensetzungen zur behandlung der vorhof-fibrillation | |
WO1998006400A3 (en) | Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells | |
IL148196A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
MX9206930A (es) | Nuevos compuestos | |
IL169577A0 (en) | Oligosaccharide derivatives and pharmaceutical compostions containing the same | |
DE69925225D1 (de) | Propylaxe und behandlung der arzneimittel induzierten nierenstörungen | |
WO2000024389A3 (en) | Benzoquinoline derivatives useful as antibacterial agents | |
DE69424677D1 (de) | Präparat zur behandlung der drogenabhängigkeit | |
WO2002081462A8 (en) | Aminoflavone compounds, compositions, and methods of use thereof | |
CA2236078A1 (en) | Prophylactic or therapeutic agents for diseases associated with dysfunction of nos | |
TH52554A (th) | สารประกอบ 2,3-ซับสทิทิวเท็ดอินโดล ที่เป็นสารต่อต้านการอักเสบ และเป็นสารบรรเทาความปวด |